Johnson & Johnson vs. Rhythm Pharmaceuticals, Inc. Common Stock
JNJ
Johnson & Johnson
$269.47 -0.19%
VS RYTMRhythm Pharmaceuticals, Inc. Common Stock
$104.71 +2.46%
Johnson & Johnson (JNJ) comes out ahead, leading on 8 of 8 compared factors.
Size & Scale
| JNJ | RYTM | |
|---|---|---|
| Market Cap | $650.65 billion | $7.21 billion |
| Revenue (TTM) | $97.93 billion | $239.92 million |
| Net Income (TTM) | $21.04 billion | $-205,346,000 |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | RYTM | |
|---|---|---|
| P/E Ratio | 31.26 | — |
| Price / Book | 7.66 | 70.01 |
| Price / Sales | 6.64 | 30.05 |
JNJ leads on 2 of 2 valuation factors.
Profitability
| JNJ | RYTM | |
|---|---|---|
| Net Margin | 21.48% | -85.59% |
| Return on Equity | 24.76% | -199.40% |
JNJ leads on 2 of 2 profitability factors.
Dividend
| JNJ | RYTM | |
|---|---|---|
| Dividend Yield | 1.99% | — |
| Payout Ratio | 62.18 | — |
JNJ and RYTM split the dividend factors evenly.
Risk & Sentiment
| JNJ | RYTM | |
|---|---|---|
| Short Interest | 0.67% | 1.12% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, RYTM overview, RYTM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.